APD418 / Pfizer 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
APD418 / Pfizer
2020-006131-10: A Study to Assess how Safe and Effective APD418 is in Patients with Heart Failure

Not yet recruiting
2
80
Europe
APD418, APD418, Solution for infusion
Arena Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc.
Treatment of acute heart failure with reduced ejection fraction (HFrEF), Treatment of acute heart failure, Diseases [C] - Cardiovascular Diseases [C14]
 
 

Download Options